Latest filing published 10 Feb 2021 for Karuna Therapeutics, Inc., €97.9M.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -45.3%Entry US$1,816.64 · Close at T+365 US$994.56
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
PureTech Health LLC: trading record in brief
PureTech Health LLC has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Adicet Bio, Inc. and Karuna Therapeutics, Inc. We count 16 filings; the first trade dates from 30 January 2018 and the latest from 9 February 2021.
Market trades split into 1 purchase (€2.8M) and 11 sales (€414.4M). Taken together, the sales exceed the purchases by €411.5M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2021, the count stands at no purchases and 1 sale.
On 10 February 2021 came the latest disclosure, an open-market sale for €97.9M in Karuna Therapeutics, Inc. The most recent open-market purchase was published on 30 January 2018, 3,205 days ago. The median gap between a trade and its publication by SEC (Form 4) is 1 day. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to PureTech Health LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,000,000 shares@ US$118.0024.1% of flowCommon StockSEC:0000899243-21-005568:0
- 1,333,333 shares@ US$76.2127.8% of flowCommon StockSEC:0000899243-20-023459:0
- 550,000 shares@ US$81.0013.2% of flowCommon StockSEC:0000899243-20-014094:0
- 5,500 shares@ US$84.500.1% of flowCommon StockSEC:0000899243-20-014094:1
- 2,100,000 shares@ US$95.6758.8% of flowCommon StockSEC:0000899243-20-001979:0
- 6,161,531 shares@ US$1.2079.5% of flowCommon StockSEC:0000899243-19-029671:0
- 205,763 shares@ US$1.242.7% of flowCommon StockSEC:0000899243-19-029467:0
- 336,561 shares@ US$1.264.6% of flowCommon StockSEC:0000899243-19-029074:0
- 59,921 shares@ US$1.250.8% of flowCommon StockSEC:0000899243-19-029074:1
- 385,884 shares@ US$1.255.2% of flowCommon StockSEC:0000899243-19-029074:2
- 531,040 shares@ US$1.257.2% of flowCommon StockSEC:0000899243-19-027581:0
- 5,194,800 sharesCommon StockSEC:0000899243-19-018912:0
- 1,751,704 sharesCommon StockSEC:0000899243-19-018912:1
- 428,895 sharesCommon StockSEC:0000899243-19-018912:2
- 7,680,700 sharesCommon StockSEC:0000899243-18-002313:0
- 233,333 shares@ US$15.0025.3% of flowCommon StockSEC:0000899243-18-002313:1Canonical exit: 30 Apr 2018 (T+90)
16 of 16 declarations
